Showing results (81-90 of 107) with videos related to
Sort By:
Pageof 11
European Journal of Obstetrics, Gynecology, and Reproductive Biology|October 6, 1999
Enhanced Fas/CD95-mediated apoptosis by epidermal growth factor in human endometrial epithelial cellsT Tanaka, K Mizuno, M Miyama, et al.Obstetrics and Gynecology|February 1, 1978
Immunosuppressive effect of serum in patients with ovarian carcinomaK Ueda, M Toyokawa, H Nakamori, et al.Fertility and Sterility|November 7, 1998
Correlation between the growth of uterine leiomyomata and estrogen and progesterone receptor content in needle biopsy specimensT Ichimura, N Kawamura, F Ito, et al.Cell and Tissue Research|June 27, 2000
Expression of vascular endothelial growth factor by granulated metrial gland cells in pregnant murine uteriC Wang, N Umesaki, H Nakamura, et al.Clinical Imaging|October 27, 2001
Positron emission tomography using 2-[(18)F] fluoro-2-deoxy-D-glucose in the diagnosis of uterine leiomyosarcoma: a case reportN Umesaki, T Tanaka, M Miyama, et al.Gynecologic and Obstetric Investigation|June 13, 1998
Power Doppler findings of adenoma malignum of uterine cervixN Umesaki, Y Nakai, K Honda, et al.Journal of Perinatal Medicine|May 22, 1998
Umbilical arterial flow change during hemodialysisY Nakai, J Nishio, S Nishimura, et al.Obstetrics and Gynecology|April 1, 1979
The prognostic value of serum immunosuppressive effect in patients with ovarian cancerK Ueda, M Toyokawa, H Nakamori, et al.American Journal of Reproductive Immunology (New York, N.Y. : 1989)|May 1, 1997
Effects of serum from pregnant versus non-pregnant women on natural killer cell activityY Fujino, Y Nakamura, K Ueda, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 13, 2007
Phase II study of irinotecan plus doxorubicin for early recurrent or platinum-refractory ovarian cancer: interim analysisS Nishimura, H Tsuda, Y Hashiguchi, et al.Pageof 11